|
Story |
The Challenge of Personalizing Health Care |
David B. Nash, MD, MBA |
webadmin |
|
Story |
Kaiser Permanente Goes All Out To Provide Access to Wellness |
Frank Diamond |
webadmin |
|
Story |
Part D in Crosshairs for 2009 |
John Liethen<br/>
and Jonathan Bakewicz |
webadmin |
|
Story |
Liability Concern Balances Medical Tourism’s Cost Appeal |
Richard Mark Kirkner |
webadmin |
|
Story |
What’s the ROI on Wellness? |
John Carroll |
webadmin |
|
Story |
Molecular Monitoring of Response In Patients With Chronic Myeloid Leukemia |
Kathryn S. Kolibaba, MD |
webadmin |
|
Story |
Bundled Payment Fails an Early Test |
Frank Diamond |
webadmin |
|
Story |
Insurers Will Find Icatibant Lifesaving but Expensive Treatment |
Thomas Morrow, MD |
webadmin |
|
Story |
Marginal increase in chief medical officer pay |
|
webadmin |
|
Blog entry |
The Final ACA Wellness Provisions and the Reticence of the EEOC |
|
Paul Terry |
|
Blog entry |
Medical Tourism: Low Cost, Satisfied Member |
|
David Kibbe |
|
Story |
Oral/Infusion Cancer Drug Parity Begins to Raise Health Plan Costs |
John Carroll |
webadmin |
|
Blog entry |
The Weight of the Nation: How Many Rounds Ahead for This Public Policy Fight? |
|
Paul Terry |
|
Story |
How much return does that PhD provide? |
|
webadmin |
|
Story |
Shining Light Or Shipwreck? |
John Carroll |
webadmin |
|
Story |
Prospective Value-Based Assessment Of New Health Care Technologies and Practices |
Christopher S. Girod |
webadmin |
|
Story |
A Conversation With Lee N. Newcomer, MD, MHA: Payments With Purpose |
John Marcille |
webadmin |
|
Story |
What if They Threw a Revolution And No Health Plans Showed Up? |
Steve Heimoff |
webadmin |
|
Story |
Barrett's Esophagus Seen In New Photodynamic Light |
Thomas Morrow, MD |
webadmin |
|
Story |
Wish List: 10 Things You Want From Your PBM |
Maureen Glabman |
webadmin |
|
Story |
For More and More Workers, Small Pay Means Small Plans |
John Carroll |
webadmin |
|
Story |
Constructing Disease Management Programs |
Mary C. Gurnee, Pharm.D. |
webadmin |
|
Story |
Antidepressant pipeline far from depressed |
|
webadmin |
|
Story |
Outcomes and Costs Associated With Initial Maintenance Therapy With Fluticasone Propionate-Salmeterol Xinafoate 250 μg/50 μg Combination Versus Tiotropium In Commercially Insured Patients With COPD |
Anand A. Dalal, PhD |
webadmin |
|
Story |
Getting Out From Under Drug Companies' Shadows |
Steve Heimoff |
webadmin |
